France Government Bond 0.75% Due 2025 logo

France Government Bond 0.75% Due 2025 (ETANZ)

Market Open
10 Aug, 15:30
XPAR XPAR
42. 49
+0.07
+0.165%
2.16B Market Cap
- P/E Ratio
- Div Yield
23,506 Volume
- Eps
42.42
Previous Close
Add Transaction
Day Range
42.49 42.49
Year Range
42.03 46.57
Want to track ETANZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ETANZ trading today higher at €42.49, an increase of 0.165% from yesterday's close, completing a monthly decrease of -3.8688% or -€1.71. Over the past 12 months, ETANZ stock lost -1.8707%.
ETANZ is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

ETANZ Chart

People also search for

S30
Solutions 30 SE
0.58
+1.5707%

France Government Bond 0.75% Due 2025 (ETANZ) FAQ

What is the stock price today?

The current price is €42.49.

On which exchange is it traded?

France Government Bond 0.75% Due 2025 is listed on XPAR.

What is its stock symbol?

The ticker symbol is ETANZ.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 2.16B.

Has France Government Bond 0.75% Due 2025 ever had a stock split?

No, there has never been a stock split.

France Government Bond 0.75% Due 2025 Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
- CEO
XPAR Exchange
- ISIN
Sweden Country
7 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

iZafe Group AB (publ) is a pioneering life-science company specialized in the research, development, and marketing of digital medical solutions and services aimed at enhancing drug management safety for individuals at home. Originally established as MediRätt AB (publ), the company underwent a name change to iZafe Group AB (publ) in May 2019, signaling its evolution and broadened ambition within the digital healthcare sector. Since its inception in 2008, iZafe Group has been committed to addressing the challenges of medication management through innovative technologies. Based in Stockholm, Sweden, the company extends its reach to consumers and care providers across Sweden, the Nordic countries, and the international market, catering to both the public and private sectors.

Products and Services

  • Dosell - an automated drug dispenser designed to simplify and secure the process of medication intake for individuals. The device is equipped to handle dose bags, facilitating easier and more independent medication management for users. Dosell ensures that medications are taken at the correct times by providing reminders and alerts for missed doses. This product highlights iZafe Group's commitment to leveraging technology to improve health outcomes and support independent living.

Contact Information

Address: David Bagares Gata 3
Phone: 46 8 21 11 21